ALEMTUZUMAB PK IN PEDIATRIC PATIENTS UNDERGOING REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT): TOWARD DOSE INDIVIDUALIZATION.

C. Emoto,R. A. Marsh, L. Neumeier, P. A. Mehta, A. A. Vinks,T. Fukuda

CLINICAL PHARMACOLOGY & THERAPEUTICS(2017)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要